Combining two existing cancer drugs could offer promise for some children with an incurable childhood brain cancer, a new study suggests.

A new type of drug that targets a genetic weakness in an untreatable childhood brain cancer could become the first ever treatment designed to target the disease. The prototype treatment could also offer hope for patients with the rare and devastating ‘stone man syndrome’ – in which muscles and ligaments turn to bone.

A gift of £110,000 from charity Abbie's Army is helping to fund a talented young scientist, who recently won an award for her research into childhood brain cancer.